Objective:

To develop a method that predicts mycobacterial treatment outcomes more accurately than minimum inhibitory concentrations (MICs), thereby improving patient care.

Key Findings:

• ASCT predicts treatment outcomes better than standard MIC assessments, indicating a need for updated clinical practices.
• Drug tolerance is a heritable trait that correlates with clinical failure, emphasizing the importance of genetic factors in treatment.
• Starvation conditions are critical for predicting treatment outcomes in tuberculosis, suggesting a need for tailored treatment approaches.
• Tolerance to certain antibiotics significantly correlates with M abscessus clearance, which could influence therapeutic decisions.
• Genetic factors influence drug tolerance and can guide treatment decisions, paving the way for personalized medicine.

Interpretation:

The study highlights the importance of understanding drug tolerance as a genetic trait, which can improve predictions of treatment outcomes beyond traditional MIC assessments, potentially transforming clinical practices.

Limitations:

• Propidium iodide reflects cell wall damage but not other killing mechanisms, which may lead to incomplete assessments of bacterial viability.
• ASCT does not account for host immunity, drug penetration, toxicity, and adherence, which are critical factors in real-world treatment scenarios.

Conclusion:

The ASCT method provides a scalable framework for translating in vitro killing into in vivo efficacy, paving the way for improved drug development and personalized therapy, and suggesting avenues for future research.